NEXIEN BIOPHARMA, INC. Total Liabilities
NEXIEN BIOPHARMA, INC. had Total Liabilities of $458.80 thousand as of 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2025-05-14
- 2025-03-31: Liabilities $458.80K.
- 2024-12-31: Liabilities $424.00K.
- 2024-09-30: Liabilities $396.70K.
- 2024-06-30: Liabilities $365.43K.
| Period end | Liabilities |
|---|---|
| 2025-03-31 | $458.80K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $424.00K 10-Q · filed 2025-02-14 |
| 2024-09-30 | $396.70K 10-Q · filed 2024-11-18 |
| 2024-06-30 | $365.43K 10-Q · filed 2025-05-14 |
| 2024-03-31 | $339.56K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $316.81K 10-Q · filed 2024-02-20 |
| 2023-09-30 | $312.85K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $295.13K 10-K · filed 2024-10-22 |
| 2023-03-31 | $288.50K 10-Q · filed 2023-05-17 |
| 2022-12-31 | $279.29K 10-Q · filed 2023-02-08 |
| 2022-09-30 | $265.56K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $242.12K 10-K · filed 2023-09-28 |
| 2021-06-30 | $39.32K 10-K · filed 2022-09-28 |
| 2021-03-31 | $12.75K 10-Q · filed 2021-05-05 |
| 2020-12-31 | $30.38K 10-Q · filed 2021-02-11 |
| 2020-06-30 | $29.15K 10-Q · filed 2021-05-05 |
| 2017-06-30 | $91.58K 10-K · filed 2017-07-31 |
| 2017-03-31 | $86.67K 10-Q · filed 2017-05-04 |
| 2016-12-31 | $81.40K 10-Q · filed 2017-02-06 |
| 2016-09-30 | $76.61K 10-Q · filed 2016-10-19 |
| 2016-06-30 | $69.90K 10-K · filed 2017-07-31 |
| 2016-03-31 | $65.12K 10-Q · filed 2016-04-13 |
| 2015-12-31 | $59.88K 10-Q · filed 2016-02-04 |
| 2015-09-30 | $55.40K 10-Q · filed 2015-10-14 |
| 2015-06-30 | $48.91K 10-K · filed 2016-09-28 |
| 2015-03-31 | $40.82K 10-Q · filed 2015-05-06 |
| 2014-12-31 | $40.82K 10-Q · filed 2015-02-13 |
| 2014-06-30 | $484.00 10-K · filed 2015-09-15 |